Αρχειοθήκη ιστολογίου
-
▼
2023
(138)
-
▼
Φεβρουαρίου
(74)
-
▼
Φεβ 19
(9)
- Multifunctional Two-Dimensional Bi2Se3 Nanodiscs f...
- Downregulation of miR‐193a/b‐3p during HPV‐induced...
- The ability of magnetic resonance imaging to predi...
- Frequent EGFR exon 20 insertion in the so‐called p...
- Central odontogenic fibroma with amyloid: a diagno...
- Tixagevimab/Cilgavimab Treatment and Cardiovascula...
- The Ixodes ricinus salivary gland proteome during ...
- Characterization of protein-based risk signature t...
- Acute Posterior Multifocal Placoid Pigment Epithel...
-
▼
Φεβ 19
(9)
- ► Ιανουαρίου (64)
-
▼
Φεβρουαρίου
(74)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
►
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
Αναζήτηση αυτού του ιστολογίου
Πέμπτη 10 Δεκεμβρίου 2015
Pilot Comparison of 68Ga-RM2 PET and 68Ga-PSMA PET in Patients with Biochemically Recurrent Prostate Cancer
Objectives: Glu-NH-CO-NH-Lys-(Ahx)-[68Ga(HBED-CC)] (68Ga-PSMA) is a positron emission tomography (PET) tracer that can detect prostate cancer relapses and metastases by binding to the extracellular domain of PSMA. 68Ga-labeled DOTA-4-amino-1-carboxymethyl-piperidine-D-Phe- Gln-Trp-Ala-Val- Gly-His-Sta-Leu-NH2 (68Ga-RM2) is a synthetic bombesin receptor antagonist that targets gastrin-releasing peptide receptors (GRPr). We present pilot data on the biodistribution of these PET tracers in a small cohort of patients with biochemically recurrent prostate cancer (BCRPC). Methods: Seven men (mean age ± SD: 74.3±5.9 year-old) with BCRPC had both 68Ga-PSMA PET/CT and 68Ga-RM2 PET/MRI scans. The maximum standardized uptake value (SUVmax) and mean SUV (SUVmean) measurements were recorded in normal tissues and areas of uptake outside the expected physiologic biodistribution. Results: All patients had rising prostate-specific antigen (PSA) (mean±SD: 13.5±11.5) and non-contributory conventional imaging. 68Ga-PSMA had the highest physiologic uptake in the salivary glands and small bowel, with hepatobiliary and renal clearance noted, while 68Ga-RM2 had the highest physiologic uptake in the pancreas, with renal clearance noted. Uptake values uptake outside the expected physiologic biodistribution were not statistically different between 68Ga-PSMA and 68Ga-RM2; however, 68Ga-PSMA localized in a lymph node and seminal vesicle in a patient with no abnormal 68Ga-RM2 uptake. Abdominal periaortic lymph nodes were more easily visualized by 68Ga-RM2 in two patients due to lack of interference by radioactivity accumulation in the small intestine. Conclusion: 68Ga-PSMA and 68Ga-RM2 have distinct biodistribution in this small cohort of patients with BCRPC. The findings here indicate that additional work is needed to understand the expression of PSMA and GRPr in different types of prostate cancer.
from #Medicine via ola Kala on Inoreader http://ift.tt/1OV91Fk
via IFTTT
A Population Based Gaussian Mixture Model Incorporating 18F-FDG-PET and DW-MRI Quantifies Tumor Tissue Classes
The aim of our study was to create a novel Gaussian Mixture Modeling (GMM) pipeline in order to model the complementary information derived from 2-deoxy-2-(18F)-fluoro-D-glucose (18F-FDG)-Positron Emission Tomography (PET) and Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) measurements to separate the tumor microenvironment into relevant tissue compartments and follow the development of these compartments in a longitudinal manner. Methods: Serial 18F-FDG-PET and Apparent Diffusion Coefficient (ADC) maps derived from DW-MR images of NCI-H460 xenograft tumors were co-registered and a population based GMM was implemented on the complementary imaging data. The tumor microenvironment was segmented into three distinct regions and correlated with histological stainings. An analysis of covariance (ANCOVA) was applied to gauge how well the total tumor volume was a predictor for the ADC and 18F-FDG, or if ADC was a good predictor of 18F-FDG for average values in the whole tumor or average necrotic and viable tissues. Results: The co-registered PET/MR images were in excellent agreement with histology, both visually and quantitatively, and allowed for validation of the last time point measurements. Strong correlations were found for the necrotic (r = 0.88) and viable fractions (r = 0.87) between histology and the clustering. The GMM provided probabilities for each compartment with uncertainties expressed as a mixture of tissues in which the resolution of scans was inadequate to accurately separate tissues. The ANCOVA suggested that both ADC and 18F-FDG in the whole tumor (P = 0.0009, P = 0.02) as well as necrotic (P = 0.008, P = 0.02) and viable (P = 0.003, P = 0.01) tissues were a positive, linear function of total tumor volume. ADC proved to be a positive predictor of 18F-FDG in the whole tumor (P = 0.001) and necrotic (P = 0.02) and viable (P = 0.0001) tissues. Conclusion: The complementary information of 18F-FDG and ADC longitudinal measurements in xenograft tumors allows for segmentation into distinct tissues when utilizing the novel GMM pipeline. Leveraging the power of multi-parametric PET/MR imaging in this manner has the potential to take the assessment of disease outcome beyond the Response Evaluation Criteria in Solid Tumors and could provide an important impact to the field of precision medicine.
from #Medicine via ola Kala on Inoreader http://ift.tt/1OV91Fb
via IFTTT
Multiparametric analysis of the relationship between tumor hypoxia and perfusion using 18F-FAZA and 15O-H2O PET
18F-fluoroazomycin-arabinoside (18F-FAZA) is a positron emission tomography (PET) tracer of tumor hypoxia. However, as hypoxia often is associated with decreased perfusion, delivery of 18F-FAZA might be compromised, potentially disturbing the association between tissue hypoxia and 18F-FAZA uptake. The aim of this study was to gain insight in the relationship between tumor perfusion and 18F-FAZA uptake. Methods: Ten patients diagnosed with advanced non-small cell lung cancer (NSCLC) underwent subsequent dynamic 15O-H2O and 18F-FAZA PET scans with arterial sampling. Parametric images of both 15O-H2O derived perfusion (TBF) and volume of distribution (VT) of 18F-FAZA were generated. Next, multiparametric classification was performed using lesional and global thresholds. Voxels were classified as low or high TBF and 18F-FAZA VT, respectively. Finally, by combining these initial classifications, voxels were allocated to four categories (lowTBF-lowVT, lowTBF-highVT, highTBF-lowVT and highTBF-highVT). Results: A total of thirteen malignant lesions were identified in the ten patients. Average TBF and 18F-FAZA VT across all lesions were 0.45±0.20 mL·cm-3·min-1 and 0.94±0.31 mL·cm-3, respectively. The average of all lesional median values were 0.37±0.15 mL·cm-3·min-1 and 0.85±0.18 mL·cm-3 for TBF and 18F-FAZA VT, respectively. Multiparametric analysis showed that classified voxels were clustered rather than randomly distributed. Several intralesional areas could be identified where 18F-FAZA VT was inversely related to TBF. On the other hand, there were also distinct areas where TBF as well as 18F-FAZA VT were decreased or increased. Conclusion: The present data indicate that spatial variation of 18F-FAZA uptake is not necessarily inversely related with TBF. This suggests that decreased TBF may result in flow limited delivery of 18F-FAZA. Areas with both high 18F-FAZA uptake and high TBF suggest that high 18F-FAZA uptake, possibly suggesting hypoxia, may occur in regions despite having high TBF. In conclusion, multiparametric evaluation of the spatial distribution of both TBF and 18F-FAZA uptake may be helpful for understanding the 18F-FAZA signal.
from #Medicine via ola Kala on Inoreader http://ift.tt/1IZ1M91
via IFTTT
The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Behçet's syndrome
Publication date: Available online 10 December 2015
Source:The Kaohsiung Journal of Medical Sciences
Author(s): Sevil Alan, Serpil Tuna, Elif Betül Türkoğlu
Behçet's syndrome (BS) is associated with chronic inflammation and endothelial dysfunction. Although there have been extensive investigations on neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and mean platelet volume (MPV) in many diseases, their roles in BS is unclear. The purpose of the present study was to evaluate NLR, PLR, and MPV levels in BS patients and explore their clinical significance. The study included 254 patients with BS and 173 healthy individuals. Age, sex, age of onset, duration of disease, smoking, Behçet activity score, total white blood counts, neutrophil, platelet, and T lymphocyte counts of the patients were recorded. White blood cell (WBC), neutrophil, platelet, NLR, and PLR were significantly higher in patients with BS when compared with healthy controls (all p < 0.001). Lymphocyte counts and MPVs of the BS group were not statistically different from healthy controls (all p ˃ 0.05). In the BS group, PLR and MPV were significantly different among the three severity groups (p = 0.037 and p = 0.016, respectively). We showed that any laboratory markers were not associated with joint, eye, central nervous system, large vessel, or gastrointestinal involvement in BS. NLR was shown to be an independent factor for BS by multivariate analysis. We suggest that NLR can be considered to be a diagnostic criterion of BS given the support of the findings from larger prospective studies.
from #Medicine via ola Kala on Inoreader http://ift.tt/1Qig9Nd
via IFTTT
The Italian Diabetes and Exercise Study 2 (IDES-2): a long-term behavioral intervention for adoption and maintenance of a physically active lifestyle
Background: Physical activity (PA)/exercise have become an integral part of the management of type 2 diabetes mellitus (T2DM). However, current guidelines are difficult to put into action in this population due to a number of barriers, especially the lack of acceptable, feasible, and validated behavioral intervention strategies. The present manuscript reports the rationale, study design and methods, and design considerations of the Italian Diabetes and Exercise Study (IDES)-2, a randomized controlled trial testing the efficacy of a behavior change strategy in increasing total daily PA and reducing sedentary time (SED-time) in patients with T2DM.Methods/DesignStarting 7 January 2014, the IDES_2 began enrolling 300 patients with known T2DM of at least 1-year duration in three tertiary referral outpatient Diabetes Clinics in Rome. Additional requirements are age 40 to 80 years, body mass index 27 to 40 kg/m 2 , sedentary lifestyle, and physically inactive for at least 6 months, ability to walk 1.6 km without assistance, and eligibility after cardiovascular evaluation. Patients are randomized by center and within each center, by age and type of diabetes treatment to either the intervention or the control group. Patients in the intervention (INT) group (n = 150) receive theoretical and practical exercise counseling consisting of aggregated behavior change techniques (one individual theoretical counseling session plus eight twice-a-week individual theoretical and practical exercise counseling sessions) once a year for 3 years. Patients in the control (CON) group (n = 150), receive standard care, including general physician recommendations for daily PA. The primary outcomes are total daily PA and SED-time, as measured objectively by the use of an accelerometer. Secondary outcomes include physical fitness, modifiable cardiovascular risk factors, musculoskeletal disturbances, well-being/depression, and health-related quality of life.DiscussionThe behavioral intervention strategy tested in the IDES_2 is based on solid theoretical grounds and uses several behavioral change techniques, two factors which were found to improve effectiveness of behavioral intervention. In addition, physicians and exercise specialists have been specifically trained for counselling/prescribing and supervising PA/exercise, respectively, in subjects suffering from metabolic disorders. Finally, the large sample size, the long study duration, and the objective measurement of PA allow statistically significant and scientifically robust conclusions to be drawn on the feasibility and efficacy of this intervention in T2DM patients.Trial registrationClinicalTrials.gov; NCT01600937; 10 October 2012.
from #Medicine via ola Kala on Inoreader http://ift.tt/1QzuWlm
via IFTTT
-
Pharmaceutics Pharmaceutics, Vol. 12, Pages 832: Optimized Birch Bark Extract-Loaded Colloidal Dispersion Using Hydrogenated Phospholipid...
-
Vaccines Vaccines, Vol. 8, Pages 492: Anti-Flavivirus Vaccines: Review of the Present Situation and Perspectives of Subunit Vaccines Prod...
-
Cells Cells, Vol. 9, Pages 2002: Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma Cells, Vol. 9, Pages...